Alta Semper Capital has signed a deal to exit its Egypt-based healthcare products manufacturing portfolio company in an initial public offering (IPO). The listing has placed a market valuation of approximately $178 million on the company.
The investor has listed Macro Pharmaceuticals on the Egyptian Exchange (EGX), exiting alongside a consortium of shareholders.
Source: Private Equity Africa.